期刊文献+

胃癌组织中表皮生长因子受体及蛋白激酶表达程度与临床病理特征的关系 被引量:1

The relationships of clinical pathological characteristics with the expressions epidermal growth factor receptor and protein kinase B in the gastric carcinomas
原文传递
导出
摘要 目的探讨胃癌组织中表皮生长因子受体(EGFR)和蛋白激酶(AKT)表达情况与胃癌的临床病理特征相关性。方法用免疫组化的方法分别检测153例胃癌患者的癌组织和癌旁正常胃组织中EGFR、AKT的表达程度,分析其与患者临床病理特征的相关性。结果在不同的性别、年龄及不同肿瘤病理类型、分化程度的患者中,胃癌组织EGFR、AKT的表达程度比较差异无统计学意义(P〉0.05)。EGFR水平与TNM分期有关(X2=5.43,P〈0.05);AKT的表达水平与肿瘤大小,T分期,TNM分期有关(x2=4.73、4.95、5.32,P〈0.05或P〈0.01);出现淋巴结转移及远处转移的胃癌组织中AKT(X2=4.83、4.75,p〈0.05)、EGFR(X2=4.67,4.58,P〈0.05)表达水平分别较无转移者高。结论检测胃癌组织中EGFR、AKT的表达对于胃癌的诊断、疾病的分期和转移的判断有一定的参考意义。 Objective To explore the association between clinical pathological characteristics and the expressions of epidermal growth factor receptor (EGFR) and protein kinase B (AKT) in gastric carcinomas. Methods The expressions of EGFR and AKT were measured with immunohistochemical method in the cancer tissues and cancer-adjacent normal tissues from 153 cases of patients with gastric cancer. The association between clinical pathological characteristics and their expressions were analyzed. Results The expressions of AKT and EGFR in gastric cancer tissues had no relationship with gender, age, pathological type, and the degree of differentiation ( P 〉 0.05). A positive correlation was existed between the EGFR and TNM stages (X2 = 5.43, P 〈 0. 05 ). The AKT was positively related to the size, T stage, and TNM stage of the tumor, respectively (X2 = 4. 73, 4. 95,5.32, P 〈 0.05 or P 〈 0. 01 ). The levels of AKT (X2 =4. 83,4. 75, P 〈 0. 05)and EGFR( X2 = 4. 67,4. 58, P 〈 0. 05) in the gastric cancer tissues with lymph node and/or distant metastasis were significantly higher than the gastric cancer tissues without metastasis, respectively. Conclusions The over-expressions of AKT and EGFR would benefit the diagnosis and stages of a gastric cancer and the determination of its metastasis.
出处 《中国医师杂志》 CAS 2012年第11期1486-1489,共4页 Journal of Chinese Physician
关键词 受体 表皮生长因子 分析 蛋白激酶类 分析 胃肿瘤 病理学 Receptor, epidermal growth factor/analysis Protein kinases/analysis Stomach neo-plasms/pathology
  • 相关文献

参考文献14

  • 1Galizia G,Lieto E,Orditura M. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery[J].World Journal of Surgery,2007,(07):1458-1468.
  • 2Zhang Y,Zheng L,Zhang J. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo[J].Planta Medica,2011,(16):1774-1781.
  • 3Jin X,Yin J,Kim SH. EGFR-AKT-Smad signaling promotes formtion of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction[J].Cancer Research,2011,(22):7125-7134.
  • 4Mitsudomi T,Yatabe Y. Epidermal growth factor receptor in relation to tumor development:EGFR gene and cancer[J].FEBS Journal,2010,(02):301-308.
  • 5杨方.乳腺癌中EGFR和CXCR4的表达及其意义[J].医学临床研究,2010,27(9):1647-1649. 被引量:2
  • 6E1-Rayes BF,LoRusso PM. Targeting the epidermal growth factor receptor[J].British Journal of Cancer,2004,(03):418-424.
  • 7Coticchia CM,Revankar CM,Deb TB. Calmodulin modulates Akt activity in human breast cancer cell lines[J].Breast Cancer Research and Treatment,2009,(03):545-560.doi:10.1007/s10549-008-0097-z.
  • 8Wei Q,He W,Lu Y. Effect of the tumor suppressor gene ING4 on the proliferation of MCF-7 human breast cancer cells[J].Oncol Lett,2012,(03):438-442.
  • 9邸旭.胃癌组织中EGFR的表达变化及意义[J].山东医药,2011,51(6):66-67. 被引量:4
  • 10Lieto E,Ferraraccio F,Orditura M. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients[J].Annals of Surgical Oncology,2008,(01):69-79.

二级参考文献26

  • 1Andreopoulou E, Hortobagyi G N. Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy[J]. J Clin Oncol , 2008, 26 (22): 3660- 3662.
  • 2Masood S. Prognostic/predictive factors in breast cancer[J]. Clin Lab Med , 2005,25 (4) : 809-825.
  • 3Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma[J]. Br J Cancer , 1996,73 (7) : 931- 934.
  • 4Xu H, Yu Y, Marciniak D, et al . Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells[J]. Mol Cancer Ther ,2005,4(3) :435-442.
  • 5Blot E, Laberge-Le CS, Jamali H, et al . CXCR4 membrane expression in node-negative breast cancer [J].Breast J , 2008,14(3) : 268-274.
  • 6Singh S, Singh UP, Grizzle WE, et al . CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion[J]. Lab Invest , 2004,84 (12) : 1666-1676.
  • 7Buchholz TA, Tu X, Ang KK, et al . Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicinbased neoadjuvant chemotherapy[J]. Cancer , 2005,104 (4) : 676-681.
  • 8Mori T, Doi R, Koizumi M, et al . CXCR4 antagonist inhibits stromal cell derived factor 1-induced migration and invasion of human pancreatic cancer[J]. Mol Cancer Ther , 2004,3 (1) : 29-37.
  • 9Tarasova NI, Stauber RH, Michejda CJ. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4[J]. J Biol Chem ,1998,273(26):15883-15886.
  • 10Zlotnik A. Chemokines and cancer[J], Int J Cancer ,2006, 119(9) .-2026-2029.

共引文献7

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部